Merck Foundation trains oncology workers across 27 African countries

A single number anchors this story: 27. That is how many African countries have now received specialised oncology training through a partnership between the Merck Foundation and the Tata Memorial Centre (TMC), according to the Ghanaian Times.

Ghana is among the countries where health workers have participated in the programme. The training is designed to build local clinical capacity — placing oncology skills in the hands of practitioners on the continent rather than relying on referral abroad.

The Merck Foundation and TMC did not release a full breakdown of participating countries or the number of health workers trained in the Ghanaian Times report. The scope of the partnership, spanning more than half of the continent's nations, points to an effort operating at scale.

For people with albinism, access to trained oncology staff is not an abstract policy question. Melanin does not accumulate in the skin of people with albinism, leaving them with little protection against ultraviolet radiation. Skin cancer — particularly squamous cell carcinoma — develops at significantly higher rates and earlier ages in this population than in the general population, according to research published in the Journal of Skin Cancer. In many parts of Sub-Saharan Africa, dermatology and oncology services remain thinly distributed, and late diagnosis is common.

The Ghanaian Times report did not specify whether the training included dermatology-focused oncology or content relevant to high-risk populations such as people with albinism. That gap in the reporting is worth holding.

What the programme represents, at minimum, is a wider base of health workers who understand cancer staging, treatment options, and referral pathways — infrastructure that benefits anyone who needs it, including a community for whom skin cancer is a persistent and serious risk.